For patients with non-melanoma skin cancer (NMSC) of the face or neck, the greatest deterioration in quality of life (QoL) during the treatment period occurs at the time of diagnosis, researchers report online ahead of print in Journal of Cancer Education (June 4, 2020).
Findings from a new study of autologous stem cell treatments for sun damage have shown this treatment approach results in a replacement of the sun-damaged elastin structures in the dermis within a few weeks.
Researchers from Emory University in Atlanta have isolated two triterpenoid acids that appear to inhibit the ability of methicillin-resistant Staphylococcus aureus (MRSA) to produce the tissue-damaging toxins that impair wound healing.
Senior author Dr. Håkan Olsson said: “Previous studies have shown that the same antihistamines have survival benefits in breast cancer. Now we see the same thing concerning malignant melanoma. However, more research is required to confirm the results.”